Showing 2,021 - 2,040 results of 103,572 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 0.90s Refine Results
  1. 2021

    Scaling Laws for the Influence of Gravity and Its Gradient on Dropwise Condensation: A Simulation Study by Chen Ma (714759)

    Published 2024
    “…We also identify a critical gravitational acceleration determined by nucleation density, above which a counterintuitive trend emerges: the heat flux decreases with increasing gravitational acceleration. …”
  2. 2022

    Scaling Laws for the Influence of Gravity and Its Gradient on Dropwise Condensation: A Simulation Study by Chen Ma (714759)

    Published 2024
    “…We also identify a critical gravitational acceleration determined by nucleation density, above which a counterintuitive trend emerges: the heat flux decreases with increasing gravitational acceleration. …”
  3. 2023
  4. 2024

    CC-1<sup>+</sup> immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks. by Krista A. Dent (709531)

    Published 2015
    “…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1<sup>+</sup> oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”
  5. 2025
  6. 2026
  7. 2027

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  8. 2028

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  9. 2029
  10. 2030
  11. 2031
  12. 2032
  13. 2033

    In we present the number of modules determined by DMSP on various values of connectivity density by Ioannis A Maraziotis (86282)

    Published 2011
    “…When we apply stricter criteria (as in red dotted line) there is a slight decrease in the number of the modules but at the same time the connectivity density values are better. …”
  14. 2034
  15. 2035
  16. 2036
  17. 2037
  18. 2038
  19. 2039
  20. 2040